Issues: Vax Specific

Anthrax

Hepatitis B

Hib

HPV

Influenza

Lyme Disease
Meningococcal

MMR    

Polio

Rotavirus

● Smallpox

Tdap/Td

Varicella

Yellow Fever

 

Issues: Misc

Exemptions

Legislation 

New Vax Status

Thimerosal

Independent Vax  Safety Board

 

Vaccine Info

2011 Schedule

ACIP Recs

Components
IOM Reports

● Vax Injury Comp Program
Manufacturer Links

Package Inserts

Reporting AEs

Thimerosal Table

VAERS

VISs

 

Links
 

Search
 

About IVS

Faculty Biographies

Publications

Donations

 

Email IVS

 

Disclaimers & Privacy
 

 

Institute for Vaccine Safety

Johns Hopkins Bloomberg School of Public Health

615 N. Wolfe Street

Room W5041

Baltimore, MD 21205

www.vaccinesafety.edu

 

 

 

 

Components of
Hib & Hepatitis B Vaccine

Excipients Table
Allergens Table
Components Table
 

Indication

For immunization against Haemophilus influenzae type b and against infection caused by all known subtypes of Hepatitis B virus in infants  born of HBsAg-negative mothers

Proprietary Name

Comvax

Manufacturer

Merck

Viability

Inactivated

Microorganism

H. influenzae type b, Virus family Hepadnaviridae

Approved Ages

6 weeks - 15 months

Dose

0.5 mL

Route

Intramuscular

Dose form

Suspension

Appearance

Slightly opaque, white suspension

Concentration (per 0.5 mL)

Hib polysaccharide, 7.5 mcg

Hepatitis B surface antigen, 5 mcg

Excipients

Aluminum (as amorphous aluminum hydroxide), 225 mcg

Sodium borate (decahydrate) as pH stabilizer, 35 mcg

Yeast protein, ≤1%

Formaldehyde, ≤0.0004%

Adjuvant

Neisseria meningitides OMP, 125mcg

Aluminum (as amorphous aluminum hydroxide), 225 mcg

Allergens

Vial stopper contains dry natural latex rubber

Preservatives

None

Media

Hib: Complex fermentation media

Hepatitis B: S. cerevisiae

Packaging

Box of 10 single-dose vials

Routine storage

2 to 8° C (36-46° F)

Do Not Freeze

Package Insert Date

December 2010

updated January 2011

This page was last updated on October 03, 2011

© 2011 Institute for Vaccine Safety